You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 15, 2024

Litigation Details for BAUSCH HEALTH IRELAND LIMITED v. PADAGIS ISRAEL PHARMACEUTICALS LTD (D.N.J. 2020)


✉ Email this page to a colleague

« Back to Dashboard


Small Molecule Drugs cited in BAUSCH HEALTH IRELAND LIMITED v. PADAGIS ISRAEL PHARMACEUTICALS LTD
The small molecule drugs covered by the patents cited in this case are ⤷  Subscribe and ⤷  Subscribe .

Details for BAUSCH HEALTH IRELAND LIMITED v. PADAGIS ISRAEL PHARMACEUTICALS LTD (D.N.J. 2020)

Date Filed Document No. Description Snippet Link To Document
0000-00-00 External link to document
2020-05-01 1 infringement of U.S. Patent Nos. 8,809,307 (the “’307 Patent”) and 10,478,502 (the “’502 Patent”) (collectively…for infringement of the Patents-In-Suit. This action arises under the Patent Laws of the United States… THE PATENTS-IN-SUIT The ’307 Patent 18. …the ’307 Patent is attached as Exhibit A. 19. The named inventors of the ’307 Patent are Arturo… ’307 Patent as November 2, 2031. 21. Bausch Ireland is the assignee of the ’307 Patent. External link to document
2022-05-20 144 Order on Motion for Summary Judgment Bausch owns U.S. Patent Nos. 10,251,895 (“the ’895 patent”) and 10,426,787 (the “’787 patent,” and together…States Patent Application No. 15/173,961 ultimately issued as the ’895 patent. United States Patent Application…together with the ’895 patent, the “Combination Patents”). For the reasons that follow, Plaintiffs’ motion…903,785 ultimately issued as the ’787 patent. The Combination Patents have the same inventors, both claim…8362 Patent Application No. 15/903,785, which was filed on June 18, 2015, and the two patents have External link to document
2022-09-21 196 Order on Motion in Limine AND Order on Motion in Limine AND Order on Motion in Limine AND Order on Motion in Limine AND Order on Motion in Limine AND Order on Motion in Limine Bausch owns U.S. Patent Nos. 10,251,895 (“the ’895 patent”), 10,426,787 (“the ’787 patent,” and together…together with the ’895 patent, the “Combination Patents”), 8,809,307 (“the ’307 patent”) and 10,478,502 (…reduction . . .” (Claim 1 of the ‘787 patent; claim 1 of the ‘895 patent.) The language of the relevant…produces” test has a foundation in either the patents or patent law; this Court rejects Defendants’ argument…starring role in the patent specifications, as IDP-118 has in the Combination Patents. There is nothing External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.